Treatable renal failure found in non-ambulatory Duchenne muscular dystrophy patients

Highlights • We describe Duchenne muscular dystrophy (DMD) patients with treatable renal failure. • CystatinC is a useful marker of kidney function in reduced muscle mass cases. • Non-ambulatory DMD patients are at a risk of reduced kidney perfusion.

Saved in:
Bibliographic Details
Published in:Neuromuscular disorders : NMD 2015-10, Vol.25 (10), p.754-757
Main Authors: Motoki, Takahiro, Shimizu-Motohashi, Yuko, Komaki, Hirofumi, Mori-Yoshimura, Madoka, Oya, Yasushi, Takeshita, Eri, Ishiyama, Akihiko, Saito, Takashi, Nakagawa, Eiji, Sugai, Kenji, Murata, Miho, Sasaki, Masayuki
Format: Article
Language:English
Subjects:
Adolescent
Adult
Blood Urea Nitrogen
Chronic renal hypoperfusion
Cystatin C
Cystatin C - blood
Drinking
Duchenne muscular dystrophy
Dystrophin - genetics
Humans
Male
Muscular Dystrophy, Duchenne - blood
Muscular Dystrophy, Duchenne - complications
Mutation
Neurology
Non-ambulatory
Renal failure
Renal Insufficiency - blood
Renal Insufficiency - complications
Renal Insufficiency - diagnosis
Renal Insufficiency - prevention & control
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • We describe Duchenne muscular dystrophy (DMD) patients with treatable renal failure. • CystatinC is a useful marker of kidney function in reduced muscle mass cases. • Non-ambulatory DMD patients are at a risk of reduced kidney perfusion.
ISSN:0960-8966
1873-2364
DOI:10.1016/j.nmd.2015.07.006